Tuesday , January 16 2018
Home / Resources / Polls / Switching to Basaglar

Switching to Basaglar

Will you consider switching over your Lantus users to Lilly’s new basal insulin Basaglar, 

which is not approved as a biosimilar product, but has the same exact properties as Lantus and will likely be less expensive?

View Results

Loading ... Loading ...